Search results
Results from the WOW.Com Content Network
A bottom-line whiff and reduced guidance made the company an outlier for the wrong reasons on Hump Day.
In other words, the stock price you see today, or even tomorrow, is less likely to be based on facts and more likely to be based on investor sentiments in that moment.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. [2] ...
Viatris Pharmaceutical Plant in Istanbul. 27 may 2023. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. [ 31 ] It owns brands (like Viagra , Xanax , Lipitor ), [ 6 ] [ 32 ] generics , including branded and complex generics, biosimilars , [ 33 ] [ 34 ] and over-the-counter (OTC ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This was above analysts' estimate of $2.42 billion, according to Refinitiv data. The beat was driven by strong uptake of its top-selling drug Trikafta, which recorded sales of $2.24 billion in the ...
IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services.
"If we have efficacy data, we hope we'll have them any time from September onward," Dr. Mene Pangalos, executive vice president for AstraZeneca’s biopharmaceuticals research and development ...